表紙
市場調査レポート

インスリンデリバリーシステム市場の分析:2008-2012年

Insulin Delivery Systems Market Analysis (2008-2012)

発行 RNCOS E-Services Pvt. Ltd. 商品コード 146111
出版日 ページ情報 英文 110 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
インスリンデリバリーシステム市場の分析:2008-2012年 Insulin Delivery Systems Market Analysis (2008-2012)
出版日: 2011年02月01日 ページ情報: 英文 110 Pages
概要

2030年には全世界で4億3800万人の糖尿病患者が発生すると予測されています。この動きに合わせて、糖尿病の新たな治療法や、それに用いる機器の開発への需要も高まるものと考えられます。

当レポートでは、世界の糖尿病治療法とそのための医療機器の開発状況、特にインスリンデリバリーのための機器の技術・市場動向について調査し、全世界および各国での市場動向、個別製品の詳細、新しい機器の開発動向、主要企業プロファイルなどの情報を盛り込み、概略以下の構成でお届けします。

第1章 アナリストの見解

第2章 分析手法

第3章 世界の糖尿病治療薬市場の概要

第4章 主な市場促進・制約要因

第5章 世界のインシュリン市場の概況

  • インド
  • 中国
  • 米国
  • ロシア
  • ブラジル

第6章 インシュリンデリバリー機器

  • ペン型注射器
    • メカニズムと技術
    • 市場分析
    • 主な企業・製品
    • 賛成・反対意見
    • 近年の開発
  • インスリンポンプ
    • メカニズムと技術
    • 市場分析
    • 賛成・反対意見
    • 主な企業・製品
    • 近年の開発
  • インスリン注射器
    • メカニズムと技術
    • 市場分析
    • 賛成・反対意見
    • 主な企業・製品
    • 近年の開発
  • インスリンジェットインジェクター
    • メカニズムと技術
    • 市場分析
    • 賛成・反対意見
    • 主な企業・製品

第7章 新規開発された機器

  • 移植型インスリンポンプ
  • インスリン吸入器
  • インスリンピル:インスリンの経口投与
  • 糖尿病用ワクチン
  • 人造膵臓
  • MEMS技術
  • インスリンパッチ

第8章 近年共同開発と企業買収

第9章 主な企業

  • Eli Lilly
  • Novo Nordisk
  • Sanofi Aventis
  • Becton Dickinson
  • Medtronic
  • F. Hoffmann La Roche
  • Animas Corporation
  • LifeScan
  • Bayer
  • Abbott Laboratories
  • Insulet Corporation

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Estimations suggesting that there will be 438 Million diabetic people in 2030 have alarmed the global community. With such high expected rates of growth in the diabetic population, the demand for diabetes solutions are forecasted to register continuously increasing growth rates. Growth of diabetes solutions market has caused a ripple effect in related markets, such as the specialty foods market and the testing equipments and delivery devices market. Manufacturers and service providers in all these sectors have to recognize the special needs of diabetics to cater to this growing population.

Our recent research study “Insulin Delivery Systems Market Analysis (2008-2012)”, states that currently the insulin market is characterized by the emergence of new drug delivery devices with improved technology and this trend is likely to continue in next few years also on the back of government initiatives. Hence, global insulin market is forecasted to grow at a CAGR of around 20% during 2010-2015. Anticipating the future growth, pharma giants are making investments in active R&D to increase their market share.

Our report highlights that traditionally, insulin delivery has been dominated by syringes. Besides, the introduction of insulin pens has seen a paradigm shift in the insulin delivery devices market. On the other hand, insulin pumps have seen a significant growth in market penetration due to technological advances that make the process less cumbersome at competitive prices. Further, the continuous glucose monitoring systems used in conjunction with insulin pumps provide greater control over the management of diabetes. Finally, the needle-free injection jets are also an up-and-coming technology in insulin delivery.

Our report provides systematically searched information and reliable statistical data of the global insulin-delivery Devices market, with focus on providing brief overview of the traditional delivery devices and new emerging technological products. The report also gives an insight into the prevailing trends in the major geographical markets across the globe to comprehend the market dynamics. Besides, the report contains analysis of market size, growth, share, segmentation and recent developments to facilitate clients understand opportunities and challenges to take strategic decisions. In addition, the report has carefully examined the global insulin-delivery devices market in terms of latest industrial collaborations and competitive landscape to identify the hidden potential growth segments.

Table of Contents

1. Analyst View

2. Research Methodology

3. Global Diabetes Drug Market Overview

4. Key Market Drivers and Restraints

5. Global Insulin Market Overview

  • 5.1. India
  • 5.2. China
  • 5.3. US
  • 5.4. Russia
  • 5.5. Brazil

6. Insulin Delivery Devices

  • 6.1. Insulin Pens
    • 6.1.1. Mechanism and Technologies
    • 6.1.2. Market Analysis
    • 6.1.3. Key Players & Products
    • 6.1.4. Pros and Cons
    • 6.1.5. Recent Developments
  • 6.2. Insulin Pumps
    • 6.2.1. Mechanism and Technologies
    • 6.2.2. Market Analysis
    • 6.2.3. Pros and Cons
    • 6.2.4. Key Players & Products
    • 6.2.5. Recent Developments
  • 6.3. Insulin Syringes
    • 6.3.1. Mechanism and Technology
    • 6.3.2. Market Analysis
    • 6.3.3. Pros and Cons
    • 6.3.4. Key Players & Products
    • 6.3.5. Recent Developments
  • 6.4. Insulin Jet Injectors
    • 6.4.1. Mechanism and Technologies
    • 6.4.2. Market Analysis
    • 6.4.3. Pros and Cons
    • 6.4.4. Key Players & Products

7. Emerging Devices

  • 7.1. Implantable Insulin Pumps
  • 7.2. Insulin Inhalers
  • 7.3. Oral Insulin/Insulin Pill
  • 7.4. Vaccine against Diabetes
  • 7.5. Artificial Pancreas
  • 7.6. MEMS Technology
  • 7.7. Islet Cell Transplantation
  • 7.8. Insulin Patch

8. Recent Collaborations & Acquisitions

9. Key Players

  • 9.1. Eli Lilly
  • 9.2. Novo Nordisk
  • 9.3. Sanofi Aventis
  • 9.4. Becton Dickinson
  • 9.5. Medtronic
  • 9.6. F. Hoffmann La Roche
  • 9.7. Animas Corporation
  • 9.8. LifeScan
  • 9.9. Bayer
  • 9.10. Abbott Laboratories
  • 9.11. Insulet Corporation

List of Figures:

  • Figure 3-1: Global - Number of Diabetic Patients (Million), 2010 & 2030
  • Figure 3-2: Global - Number of Patients with Diabetes by Age-Group (Million), 2010 & 2030
  • Figure 3-3: Global - Healthcare Expenditure on Diabetes (Billion US$), 2010 & 2030
  • Figure 5-1: Global - Insulin Market (Billion US$), 2008-2010
  • Figure 5-2: Global - Forecast for Insulin Market (Billion US$), 2011-2015
  • Figure 5-3: Global - Insulin Demand (Kg), 2006 & 2012
  • Figure 5-4: Global - Share of Key Insulin Products (2009)
  • Figure 5-5: India - Insulin Market (Million US$), 2009 & 2015
  • Figure 5-6: India - Share of Key Players in Insulin Market (2010)
  • Figure 5-7: China - Insulin Market (Million US$), 2010-2015
  • Figure 5-8: China - Share of Key Players in Insulin Market (Q2 2010)
  • Figure 5-9: US - Share of Key Players in Modern Insulin Market (Q2 2010)
  • Figure 5-10: Russia - Insulin Market (Million US$), 2009-2011
  • Figure 5-11: Russia - Share of Key Players in Insulin Market (H1 2009)
  • Figure 5-12: Brazil - Insulin Market (Million US$), 2008-2011
  • Figure 5-13: Brazil - Shares of Key Players in Insulin Market (2010)
  • Figure 6-1: US - Insulin Pen Devices Market (Million US$), 2008-2010
  • Figure 6-2: US - Forecast for Insulin Pen Devices Market (Million US$), 2011-2015
  • Figure 6-3: Global - Share of Key Players in Pen Devices Market
  • Figure 6-4: Global - Insulin Pumps Market (Million US$), 2008-2010
  • Figure 6-5: Global - Forecast for Insulin Pumps Market (Million US$), 2011-2015
  • Figure 6-6: Global - Share of US and Non-US in Insulin Pumps Market (2010)
  • Figure 6-7: Global - Forecast for Share of US and Non US in Insulin Pumps Market (2015)
  • Figure 6-8: US - Insulin Pumps Market (Million US$), 2008-2010
  • Figure 6-9: US - Forecast for Insulin Pumps Market (Million US$), 2011-2015
  • Figure 6-10: Non-US - Insulin Pumps Market (Million US$), 2008-2010
  • Figure 6-11: Non-US - Forecast for Insulin Pumps Market (Million US$), 2011-2015
  • Figure 6-12: Global - Share of Key Players in Insulin Pumps Market (2009)
  • Figure 6-13: US - Insulin Syringes Market (Million US$), 2008-2010
  • Figure 6-14: US - Forecast for Insulin Syringes Market (Million US$), 2011-2015
  • Figure 6-15: US - Insulin Jet Injectors Market (Million US$), 2008-2010
  • Figure 6-16: US - Forecast for Insulin Jet Injectors Market (Million US$), 2011-2015

List of Tables:

  • Table 3-1: Global - Diabetic Population of Top 10 Countries (Million), 2010 & 2030
  • Table 5-1: India - Diabetic Patients in Age Group 20-79 Years (‘000), 2010 & 2030
  • Table 5-2: China - Diabetic Patients in Age Group 20-79 Years (‘000), 2010 & 2030
  • Table 5-3: US - Diabetic Patients in Age Group 20-79 Years (‘000), 2010 & 2030
  • Table 5-4: Russia - Diabetic Patients in Age Group 20-79 Years (‘000), 2010 & 2030
  • Table 5-5: Brazil - Diabetic Patients in Age Group 20-79 Years (‘000), 2010 & 2030
  • Table 6-1: Key Insulin Pen Products by Company
  • Table 6-2: Key Insulin Syringes Products by Manufacturer
Back to Top